Wolff Wiese Magana LLC Seagen Inc. Transaction History

Wolff Wiese Magana LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$142.57 - $190.86 $2,708 - $3,626	-19 Reduced 48.72%	20 $3,000
Q3 2021 Oct 15, 2021	SELL	$142.45 - $169.82 $2,849 - $3,396	-20 Reduced 33.9%	39 $7,000
Q1 2021 Apr 15, 2021	SELL	$137.51 - $190.8 $117,708 - $163,324	-856 Reduced 93.55%	59 $8,000
Q4 2020 Jan 27, 2021	BUY	$164.63 - $211.93 $150,636 - $193,915	915 New	915 $160,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Wolff Wiese Magana LLC, based on Form 13F filings with the SEC.

Stay updated on Wolff Wiese Magana LLC with notifications on news.